The research of the Department of Biochemistry and Molecular Pharmacology is aimed at the structural and functional study of specific and pharmacologically relevant gene products.
One of the principle goals is the identification of new proteins that could represent targets for drug therapy. Potential drug-protein interactions are studied also at the molecular level, using a wide variety of approaches ranging from studies performed on animal models to computational simulations.
Development of new drugs for the treatment of acute myeloid leukemia
REMEDi4ALL: Building a Sustainable European Innovation Platform to Enhance the Repurposing of Medicines for All
Ente finanziatore: HORIZON EUROPE
Area di ricerca: Drug repositioning
EATRIS-CONNECT: Providing the pathway for the digital transformation of EATRIS
Ente finanziatore: HORIZON EUROPE
Area di ricerca: Health Data Science
OSIRIS: Open science to increase reproducibility in science
Ente finanziatore: European Union
Area di ricerca: Open science
MIMIC-Key: A key to the rational design of extracellular vesicles-mimicking nanoparticles
Ente Finanziatore: Commissione Europea
Area di ricerca: nanoparticles
ECLipse: ECL-based Infectious Pathogen (bio)Sensor
Ente Finanziatore: Commissione Europea
Area di ricerca: diagnostica
Smyle: Smart systems for the targeting and killing of mesothelioma tumors
Ente Finanziatore: Ministero della Salute (progetto fondi PNRR NextGenerationEU)
Area di ricerca: nanotecnologie
BioSilicaThera: Biomarker-responsive DNA-based organosilica nanoparticles for theranostics
Ente Finanziatore: Ministero dell'Università e della Ricerca (progetto fondi PNRR NextGenerationEU)
Area di ricerca: nanoparticelle
Biocompatible and Versatile Strategy to Achieve Brain Multi-Drugs Delivery with Dual-Controlled Release of Neuroactive Compounds After Intranasal Administration
Ente Finanziatore: Commissione Europea (HORIZON-MSCA-2022-PF-01)
Area di ricerca: patologie neurodegenerative
POTENTIAL: Platform optimization To Enable NanomaTerIAL safety assessment for rapid commercialisation
Ente Finanziatore: Commissione Europea (HORIZON-CL4-2022-DIGITAL-EMERGING-01)
Area di ricerca: nanotossicologia
Development of innovative inhalatory targeted liposomal formulations for the treatment of inflammatory driven pulmonary fibrosis
Ente Finanziatore: Ministero della Salute
Area di ricerca: nanomedicina
INF-ACT: OneHealth Basic and Translational Research Actions addressing UnmetNeeds on Emerging Infectious Diseases
Ente Finanziatore: Ministero dell'Università e della Ricerca
Area di ricerca: Farmacologia
"Progetto Sofia": studi genomici e funzionali sulla Sindrome di Cornelia de Lange
Donazione: Dott. Gino del Bon
Area di ricerca: genomica
Studi fenomici e funzionali sulla Sindrome di Cornelia De Lange basati sull'utilizzo di colture di cellule iPSC (induced Pluripotent Stem Cells)
Ente Finanziatore: Consiglio Nazionale delle Ricerche
Area di ricerca: genomica
HEAL ITALIA - Health Extended Alliance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine
Ente Finanziatore: Ministero dell'Università e della Ricerca (NextGenerationEU -PNRR)
Area di ricerca: oncologia
The Research Center for Amyotrophic Lateral Sclerosis (ALS Center) brings together the groups that are involved in ALS research from an epidemiological, preclinicaland translational point of view.
The Center for PRECLINICAL TOXICOLOGY AND BIOCHEMISTRY includes research groups within the Department of Biochemistry and Molecular Pharmacology that have consolidated biochemical and toxicological skills.
Intercheck web: web application aimed at health professionals to support the proper prescription of drugs in the elderly.
Information service for pregnant and nursing mothers on the appropriate use of medicines.
Information service for health professionals and patients on treatment plans and rare diseases.
Information service for health professionals and patients on kidney diseases and transplants.
Information services aimed at health professionals and the general public on the correct use of drugs, side effects and interactions in the elderly.
